Ascendis Pharma A/S (ASND)
120.97
-1.83
(-1.49%)
USD |
NASDAQ |
May 17, 16:00
120.97
0.00 (0.00%)
After-Hours: 20:00
Ascendis Pharma Total Long Term Debt (Quarterly): 722.47M for March 31, 2024
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 722.47M |
December 31, 2023 | 602.96M |
September 30, 2023 | 594.14M |
June 30, 2023 | 549.82M |
March 31, 2023 | 551.09M |
December 31, 2022 | 428.09M |
September 30, 2022 | 543.78M |
June 30, 2022 | 535.05M |
March 31, 2022 | 0.00 |
December 31, 2021 | 118.84M |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.00 |
March 31, 2021 | 0.00 |
December 31, 2020 | 0.00 |
September 30, 2020 | 0.00 |
June 30, 2020 | 0.00 |
March 31, 2020 | 0.00 |
December 31, 2019 | 0.00 |
September 30, 2019 | 0.00 |
June 30, 2019 | 0.00 |
March 31, 2019 | 0.00 |
Date | Value |
---|---|
December 31, 2018 | 0.00 |
September 30, 2018 | 0.00 |
June 30, 2018 | 0.00 |
March 31, 2018 | 0.00 |
December 31, 2017 | 0.00 |
September 30, 2017 | 0.00 |
June 30, 2017 | 0.00 |
March 31, 2017 | 0.00 |
December 31, 2016 | 0.00 |
September 30, 2016 | 0.00 |
June 30, 2016 | 0.00 |
March 31, 2016 | 0.00 |
December 31, 2015 | 0.00 |
September 30, 2015 | 0.00 |
June 30, 2015 | 0.00 |
March 31, 2015 | 0.00 |
December 31, 2014 | 0.00 |
September 30, 2014 | 0.00 |
June 30, 2014 | 0.00 |
March 31, 2014 | 0.00 |
December 31, 2013 | 0.00 |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
Jun 2019
722.47M
Maximum
Mar 2024
232.31M
Average
--
Median
Jun 2019
Total Long Term Debt (Quarterly) Benchmarks
Evaxion Biotech AS | 8.648M |
Biodexa Pharmaceuticals Plc | 0.00 |
TC BioPharm (Holdings) PLC | -- |
Genmab A/S | 0.00 |
NuCana PLC | -- |